In Saudi Arabia

Prime Minister concludes productive Canada-European Union Summit

Retrieved on: 
Tuesday, June 15, 2021
Contemporary history, Conferences, Justin Trudeau, Pierre Trudeau, Politics, Canadian people, Prime Minister Trudeau, In Saudi Arabia, 47th G7 summit, Extraordinary G20 summit on COVID-19

BRUSSELS, June 15, 2021 /CNW/ - The Prime Minister, Justin Trudeau, today concluded his participation at the Canada-European Union (EU) Leaders' Summit with the President of the European Council, Charles Michel, and the President of the European Commission, Ursula von der Leyen.

Key Points: 
  • BRUSSELS, June 15, 2021 /CNW/ - The Prime Minister, Justin Trudeau, today concluded his participation at the Canada-European Union (EU) Leaders' Summit with the President of the European Council, Charles Michel, and the President of the European Commission, Ursula von der Leyen.
  • Prime Minister Trudeau also reaffirmed Canada's role as a participant in an EU permanent structured cooperation project on military mobility.
  • The last in-person Canada-EU Leaders' Summit took place in Montral in July 2019, when Prime Minister Trudeau hosted former President of the European Council, Donald Tusk.
  • Prime Minister Trudeau also reiterated that Canada will host the World Circular Economy Forum from September 13 to 15, 2021 the first time it will be hosted in North America.

EmitBio Demonstrates New Treatment Is Effective Against Multiple Types Of Coronavirus

Retrieved on: 
Thursday, February 4, 2021
Coronaviridae, Sarbecovirus, Zoonoses, Animal diseases, Bat virome, In Saudi Arabia, Severe acute respiratory syndrome coronavirus, Severe acute respiratory syndrome, Coronavirus, Middle East respiratory syndrome–related coronavirus, Variants of SARS-CoV-2, Coronavir

These findings indicate a likelihood the company's technology will also be effective against SARS-CoV-2 variants (mutations).

Key Points: 
  • These findings indicate a likelihood the company's technology will also be effective against SARS-CoV-2 variants (mutations).
  • "Over the last 20 years we have seen three life-threatening coronavirus outbreaks, SARS-CoV-1, MERS-CoV, and now SARS-CoV-2 the virus that causes COVID-19," stated Neal Hunter, Executive Chairman of EmitBio.
  • "Having this countermeasure at-the-ready will not only help current COVID-19 patients but will also provide protection against future outbreaks.
  • The research team at EmitBio welcomes inquiries and offers of scientific collaboration from the global research community.

Surfacide UV Robots Are Fighting COVID-19 in Top Pediatric Hospitals Across the US and Internationally

Retrieved on: 
Friday, December 18, 2020
Merbecovirus, Zoonoses, Bat virome, In Saudi Arabia, Electromagnetic radiation, Medicine, Medical specialties, Ultraviolet radiation, Middle East respiratory syndrome–related coronavirus, Ultraviolet, Coronavirus, Middle East respiratory syndrome

"We are grateful that so many pediatric hospitals have adopted Surfacide's powerful, trusted UV-C robot technology during these critical times," said Gunner Lyslo, Founder and CEO of Surfacide.

Key Points: 
  • "We are grateful that so many pediatric hospitals have adopted Surfacide's powerful, trusted UV-C robot technology during these critical times," said Gunner Lyslo, Founder and CEO of Surfacide.
  • *Peer-reviewed Published data from The University of Iowa discusses the efficacy of Surfacide's automated, multiple emitter UV-C system against coronavirus MERS-CoV.
  • Surfacide LLC and Surfacide Manufacturing Inc. are located in Waukesha, WI.
  • Surfacide is the only patented triple emitter UV-C system, providing the most efficient and flexible solution in the fight against viruses.

Prime Minister concludes virtual G20 Leaders' Summit

Retrieved on: 
Sunday, November 22, 2020
Conferences, Units of time, Diplomatic conferences, National Special Security Events, G20, In Saudi Arabia, Justin Trudeau, Extraordinary G20 summit on COVID-19, G20 Riyadh summit

OTTAWA, ON, Nov. 22, 2020 /CNW/ - The Prime Minister, Justin Trudeau, today concluded his participation in the G20 Virtual Leaders' Summit, hosted by the Kingdom of Saudi Arabia,and welcomed the conclusions outlined in the G20 Leaders' Declaration.

Key Points: 
  • OTTAWA, ON, Nov. 22, 2020 /CNW/ - The Prime Minister, Justin Trudeau, today concluded his participation in the G20 Virtual Leaders' Summit, hosted by the Kingdom of Saudi Arabia,and welcomed the conclusions outlined in the G20 Leaders' Declaration.
  • In virtual meetings at the Summit, Prime Minister Trudeau highlighted the importance of G20 leadership and coordinated action to beat the COVID-19 pandemic, restore economic growth, and take ambitious action to fight climate change.
  • During the Summit, the Prime Minister noted the importance of putting people at the heart of recovery efforts.
  • The G20 Virtual Leaders' Summit was an opportunity to expand global efforts to fight COVID-19, restore economic growth, and combat climate change."

GeoVax CEO David Dodd to Participate in Virtual Webinar Hosted by Outsourced Pharma

Retrieved on: 
Wednesday, October 28, 2020
Medical specialties, Health, Articles, Zoonoses, Bat virome, Sarbecovirus, Global health, In Saudi Arabia, Coronavirus, Middle East respiratory syndrome–related coronavirus, Severe acute respiratory syndrome, Novel coronavirus

These viruses can evolve to cross the animal species and infect humans and quickly spread from person to person resulting in lethal but rare respiratory infections.

Key Points: 
  • These viruses can evolve to cross the animal species and infect humans and quickly spread from person to person resulting in lethal but rare respiratory infections.
  • Recent epidemics with SARS and MERS coronaviruses resulted in 774 and 858 deaths, respectively.
  • On January 31, 2020 the WHO declared the novel coronavirus to be a global health emergency, and on March 11, 2020 the WHO declared a global pandemic.
  • The situation is fluid, with the infection and death statistics changing significantly on a regular basis.

Demand for Electronic Solutions and Strong Origination Volumes Drive Record Registrations on the MERS® eRegistry

Retrieved on: 
Wednesday, October 21, 2020
Professional services, Data management, Technology, Finance, Software, Banking, Loans, Bat virome, In Saudi Arabia, Merbecovirus, Zoonoses, Mortgage loan, eNotes, Middle East respiratory syndrome, Infectious diseases, Clinical medicine, Medicine, Mortgage Electronic Registration Systems

This activity is being driven by a number of factors, including strong industry-wide origination volumes and a movement by lenders and originators to adopt digital mortgage solutions that include eNotes.

Key Points: 
  • This activity is being driven by a number of factors, including strong industry-wide origination volumes and a movement by lenders and originators to adopt digital mortgage solutions that include eNotes.
  • An electronic note, or eNote, is the functional equivalent of a paper promissory note when created in conformity with eCommerce law requirements, and upon origination, is registered on the MERS eRegistry.
  • MERS member institutions, including lenders and originators, registered 286,403 eNotes January through September 2020, more than twice the number of eNotes registered in all of 2019.
  • Additionally, September 2020 set a record with 51,234 eNotes registered on the MERS eRegistry.

Middle East Respiratory Syndrome (MERS) Pipeline Review 2020: Therapeutic Insights into a Viral Respiratory Disease Caused by a Coronavirus (MERS-CoV) - ResearchAndMarkets.com

Retrieved on: 
Friday, October 2, 2020
Retail, Other Retail, Respiratory diseases, Medical specialties, Zoonoses, Animal diseases, Bat virome, Merbecovirus, In Saudi Arabia, Middle East respiratory syndrome–related coronavirus, Middle East respiratory syndrome, Coronavirus, Middle East respiratory syndrome coronavirus outbreak, Coronavirus disease

Middle East Respiratory Syndrome - Pipeline Review, H1 2020, provides an overview of the Middle East Respiratory Syndrome (Infectious Disease) pipeline landscape.

Key Points: 
  • Middle East Respiratory Syndrome - Pipeline Review, H1 2020, provides an overview of the Middle East Respiratory Syndrome (Infectious Disease) pipeline landscape.
  • Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a coronavirus (MERS-CoV).
  • The Middle East Respiratory Syndrome (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Middle East Respiratory Syndrome (MERS) and features dormant and discontinued projects.
  • Formulate corrective measures for pipeline projects by understanding Middle East Respiratory Syndrome (Infectious Disease) pipeline depth and focus of Indication therapeutics.

Interferon Treatment Trial 'a Major Breakthrough' Against the Pandemic

Retrieved on: 
Tuesday, July 21, 2020
Respiratory diseases, Animal diseases, Medical specialties, Zoonoses, Bat virome, In Saudi Arabia, Merbecovirus, Sarbecovirus, Middle East respiratory syndrome-related coronavirus, Severe acute respiratory syndrome, Coronavirus disease, Coronavirus

Now, the preliminary results of a clinical trial by a UK biotech have confirmed the premise advocated by the Company, suggesting that an interferon inhalation treatment for COVID-19 reduces the number of patients needing intensive care.

Key Points: 
  • Now, the preliminary results of a clinical trial by a UK biotech have confirmed the premise advocated by the Company, suggesting that an interferon inhalation treatment for COVID-19 reduces the number of patients needing intensive care.
  • In the UK study, the treatment was delivered through a nebulizer and inhaled directly into the lungs of patients with coronavirus.
  • The treatment in the study used interferon beta, as opposed to the patent-pending interferon alpha 2b (IFN-a2b) treatment developed by BetterLife called AP-003.
  • Interferon treatments have been studied against coronaviruses including MERS-CoV, SARS-Cov-1 and now SARS-CoV-2 (the causative agent of COVID-19).

As COVID Spreads, StateRecords Focuses on Single-Source Information

Retrieved on: 
Thursday, July 16, 2020
Viruses, Veterinary medicine, Zoonoses, Animal virology, Coronaviridae, In Saudi Arabia, Middle East respiratory syndrome, Coronavirus, Middle East respiratory syndrome-related coronavirus

Maryland.Staterecords.orgis covering all breaking news as well as providing statistics on the ongoing spread of the novel coronavirus.

Key Points: 
  • Maryland.Staterecords.orgis covering all breaking news as well as providing statistics on the ongoing spread of the novel coronavirus.
  • The outbreak is ongoing, and the need for consistent, reliable numbers is important for decision-making amongst the public.
  • Relaying on a single source for all information related to the virus - in this case the county governments of Maryland - can be an effective way to keep information consistent.
  • This organization also shares useful tips and advice on where to look for and access this information, as well as methods to avoid when trying to do so.

New England Biolabs' SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit Enables Visual Detection of Novel Coronavirus In 30 Minutes

Retrieved on: 
Friday, July 10, 2020
Viruses, Nidovirales, Zoonoses, Coronaviridae, Laboratory techniques, Health in Saudi Arabia, In Saudi Arabia, Middle East respiratory syndrome-related coronavirus, Coronavirus, Severe acute respiratory syndrome-related coronavirus, Severe acute respiratory syndrome, CoV

IPSWICH, Mass., July 10, 2020 /PRNewswire/ --New England Biolabs (NEB) today announced the launch of the SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit, a Research Use Only (RUO) product that can be used for the detection of novel coronavirus, SARS-CoV-2 RNA.

Key Points: 
  • IPSWICH, Mass., July 10, 2020 /PRNewswire/ --New England Biolabs (NEB) today announced the launch of the SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit, a Research Use Only (RUO) product that can be used for the detection of novel coronavirus, SARS-CoV-2 RNA.
  • The kit serves as a simple alternative to RT-qPCR and enables visual detection of amplification of SARS-CoV-2 nucleic acid in just 30 minutes.
  • "With the SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit, all you need is a simple heat source and 30 minutes to visually detect amplification of SARS CoV-2 RNA.
  • NEB,NEW ENGLAND BIOLABS, and WarmStart are registered trademarks of New England Biolabs, Inc.
    View original content to download multimedia: http://www.prnewswire.com/news-releases/new-england-biolabs-sars-cov-2-r...